Bank of Montreal’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bank of Montreal’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,500	Closed	-$16K	–	4714
2019 Q2	$16K	Hold	2,500	–	–	﹤0.01%	4290
2019 Q1	$16K	Buy	+2,500	New	+$16.6K	﹤0.01%	3731
2018 Q3	–	Sell	-10,300	Closed	-$58K	–	4724
2018 Q2	$58K	Hold	10,300	–	–	﹤0.01%	3354
2018 Q1	$53K	Buy	+10,300	New	+$55.1K	﹤0.01%	3214
2017 Q4	–	Sell	-30,000	Closed	-$188K	–	4162
2017 Q3	$188K	Sell	30,000 -28,700	-49%	-$181K	﹤0.01%	2696
2017 Q2	$360K	Sell	58,700 -31,000	-35%	-$209K	﹤0.01%	2402
2017 Q1	$658K	Buy	+89,700	New	+$414K	﹤0.01%	2003

Other funds holding AUPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bank of Montreal's AUPH Position: Q1 2022 in Review

Bank of Montreal sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2022, closing a stake of 23,108 shares — an estimated $527K sold.

Bank of Montreal first reported a position in AUPH in Q3 2014 and held it in 26 quarters. The position peaked at $4.51M in Q3 2020. 184 funds tracked by Wall St. Rank hold AUPH as of Q1 2022.

Bank of Montreal reported no remaining Aurinia Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Bank of Montreal sold 23,108 Aurinia Pharmaceuticals shares in Q1 2022, an estimated $527K.
Bank of Montreal first reported a position in Aurinia Pharmaceuticals in Q3 2014 and held it in 26 quarters.
Bank of Montreal's Aurinia Pharmaceuticals position peaked at $4.51M in Q3 2020.
184 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2022.

Based on Bank of Montreal's 13F filing for Q1 2022, filed 12 May 2022.